Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-02-04 Purchase | 2020-02-05 8:21 pm | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 38,461 | $2.6 | $99,999 | 385,415 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-07-24 Disposition | 2023-07-26 4:59 pm | N/A 2029-01-05 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 2,655,000 | $0 | 2,655,000 (Direct) | View |
2023-07-24 Option Award | 2023-07-26 4:59 pm | N/A 2029-01-05 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 2,655,000 | $0 | 2,655,000 (Direct) | View |
2023-01-08 Option Award | 2023-01-10 4:55 pm | N/A 2033-01-07 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 580,000 | $0 | 580,000 (Direct) | View |
2022-11-10 Exercise | 2022-11-14 08:13 am | N/A N/A | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 27,000 | $0.9 | 491,836 (Direct) | View |
2022-11-10 Exercise | 2022-11-14 08:13 am | N/A 2025-09-09 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 27,000 | $0 | 491,836 (Direct) | View |
2022-01-05 Option Award | 2022-01-07 5:34 pm | N/A 2032-01-04 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 500,000 | $0 | 500,000 (Direct) | View |
2021-12-14 Exercise | 2021-12-15 6:05 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 7,700 | $0.9 | 491,836 (Direct) | View |
2021-12-14 Exercise | 2021-12-15 6:05 pm | N/A 2025-09-09 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 7,700 | $0 | 491,836 (Direct) | View |
2021-01-08 Option Award | 2021-01-11 9:08 pm | N/A 2031-01-07 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 1,200,000 | $0 | 1,200,000 (Direct) | View |
2020-12-31 Exercise | 2021-01-04 8:45 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 16,000 | $0.9 | 491,836 (Direct) | View |
2020-12-31 Exercise | 2021-01-04 8:45 pm | N/A 2025-09-09 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 16,000 | $0 | 491,836 (Direct) | View |
2020-01-12 Option Award | 2020-01-13 8:06 pm | N/A 2030-01-11 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 200,000 | $0 | 200,000 (Direct) | View |
2019-12-19 Exercise | 2019-12-20 4:29 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 50,000 | $0.9 | 453,375 (Direct) | View |
2019-12-19 Exercise | 2019-12-20 4:29 pm | N/A 2025-09-09 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 50,000 | $0 | 453,375 (Direct) | View |